ES8200886A1 - Procedimiento para la preparacion de derivados del amino-1 propanol-2 - Google Patents

Procedimiento para la preparacion de derivados del amino-1 propanol-2

Info

Publication number
ES8200886A1
ES8200886A1 ES497563A ES497563A ES8200886A1 ES 8200886 A1 ES8200886 A1 ES 8200886A1 ES 497563 A ES497563 A ES 497563A ES 497563 A ES497563 A ES 497563A ES 8200886 A1 ES8200886 A1 ES 8200886A1
Authority
ES
Spain
Prior art keywords
amino
preparation
therapeutic use
propanol derivatives
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES497563A
Other languages
English (en)
Other versions
ES497563A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi SA
Original Assignee
Sanofi SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi SA filed Critical Sanofi SA
Publication of ES8200886A1 publication Critical patent/ES8200886A1/es
Publication of ES497563A0 publication Critical patent/ES497563A0/es
Granted legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/50Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D333/52Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
    • C07D333/54Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/06Antiarrhythmics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/50Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D333/78Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems condensed with rings other than six-membered or with ring systems containing such rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/50Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D333/78Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems condensed with rings other than six-membered or with ring systems containing such rings
    • C07D333/80Seven-membered rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)

Abstract

PROCEDIMIENTO PARA LA PREPERACION DE DERIVADOS DEL AMIMO-1 PROPANOL-2, DE FORMULA GENERAL (I), DONDE R1 Y R2 REPRESENTAN INDEPENDIENTEMENTE UN ATOMO / HIDROGENO, UN GRUPO ALQUILO LINEAL O RAMIFICADO CON UNO O DIEZ ATOMOS DE CARBONO, CICLOALQUILO MONO O POLICICLICO CON UNO A CATORCE ATOMOS DE CARBONO, ARILO O ARALCOILO CON UNO A CUATRO ATOMOS DE CARBONO EN LA FRACCION ALQUILO, ALCOXIALQUILO O ARILOXIALQUILO, Y N ES 1,2 O 3, Y SUS SALES DE ADICION, FARMACEUTICAMENTE ACEPTABLES. COMPRENDE LAS SIGUIENTES FASES OPERATIVAS: PRIMERA, CONDENSAR OXIMAS DE FORMULA (II) CON UNA EPIHALOHIDRINA, EN UN DISOLVENTE INERTE EN PRESENCIA DE UNA BASE Y A UNA TEMPERATURA COMPRENDIDAD ENTRE 10 GRDOS Y EL PUNTO DE EBULLICION DEL DISOLVENTE, PARA OBTENER COMPUESTOS DE FORMULA (III), DONDE N TIENE EL SIGNIFICDO YA INDICADO; SEGUNDA, CONDENSAR LOS COMPUESTOS DE FORMULA (III), CON UNA AMINA HNR1R2, DONDE R1 Y R2 TIENEN LOS SIGNIFICADOS YA INDICADOS, EN UN DISOLVENTE INERTE Y A UNA TEMPERATURA COMPRENDIDAD ENTRE 10 GRADOS Y LA TEMPERATURA DE EBULLICION DEL DISOLVENTE,
ES497563A 1979-12-21 1980-12-10 Procedimiento para la preparacion de derivados del amino-1 propanol-2 Granted ES497563A0 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7931402A FR2471980A1 (fr) 1979-12-21 1979-12-21 Nouveaux derives de l'amino-1 propanol-2, leur procede de preparation et leur application therapeutique

Publications (2)

Publication Number Publication Date
ES8200886A1 true ES8200886A1 (es) 1981-11-16
ES497563A0 ES497563A0 (es) 1981-11-16

Family

ID=9233060

Family Applications (1)

Application Number Title Priority Date Filing Date
ES497563A Granted ES497563A0 (es) 1979-12-21 1980-12-10 Procedimiento para la preparacion de derivados del amino-1 propanol-2

Country Status (26)

Country Link
US (1) US4339450A (es)
EP (1) EP0031266B1 (es)
JP (1) JPS5699472A (es)
AR (1) AR225937A1 (es)
AU (1) AU541684B2 (es)
BE (1) BE886471A (es)
BG (1) BG35047A3 (es)
CA (1) CA1158643A (es)
CH (1) CH646165A5 (es)
CS (1) CS228143B2 (es)
DE (1) DE3061928D1 (es)
DK (1) DK536180A (es)
ES (1) ES497563A0 (es)
FR (1) FR2471980A1 (es)
GB (1) GB2066808B (es)
GR (1) GR72831B (es)
HU (1) HU181774B (es)
IE (1) IE50546B1 (es)
IL (1) IL61602A (es)
IN (1) IN150867B (es)
IT (1) IT1141642B (es)
LU (1) LU83021A1 (es)
NZ (1) NZ195786A (es)
PL (1) PL127009B1 (es)
PT (1) PT72247B (es)
RO (1) RO80266B (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3704604A1 (de) * 1987-02-13 1988-08-25 Mack Chem Pharm Oximether von 2,6-dioxabicyclo(3.3.0)octanonen, herstellungsverfahren und anwendung als arzneimittel
US4803286A (en) * 1987-08-19 1989-02-07 Merck & Co., Inc. Amino-2-hydroxypropyloximinoheterocycle α-blockers
EP0347378A1 (de) * 1988-06-13 1989-12-20 Ciba-Geigy Ag Imidazol-Derivate
IL103106A (en) 1991-09-25 1998-06-15 Sanofi Elf Sites of tynocyclopentanone oximes, their preparation and pharmaceutical preparations containing them

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3398161A (en) * 1965-06-30 1968-08-20 Ici Ltd Benzo (b) thiophen derivatives which have beta-adrenergic blocking activity
NL6810133A (es) * 1968-07-18 1970-01-20

Also Published As

Publication number Publication date
PL127009B1 (en) 1983-09-30
GB2066808B (en) 1983-07-06
BE886471A (fr) 1981-04-01
BG35047A3 (en) 1984-01-16
FR2471980B1 (es) 1982-07-30
DE3061928D1 (en) 1983-03-17
NZ195786A (en) 1982-09-14
IT1141642B (it) 1986-10-01
GR72831B (es) 1983-12-06
IE50546B1 (en) 1986-05-14
AU541684B2 (en) 1985-01-17
PT72247A (fr) 1981-01-01
IT8068942A0 (it) 1980-12-18
IL61602A0 (en) 1981-09-13
GB2066808A (en) 1981-07-15
EP0031266B1 (fr) 1983-02-09
IL61602A (en) 1984-05-31
AU6558780A (en) 1981-06-25
HU181774B (en) 1983-11-28
CA1158643A (en) 1983-12-13
IE802535L (en) 1981-06-21
EP0031266A1 (fr) 1981-07-01
IN150867B (es) 1983-01-01
JPS5699472A (en) 1981-08-10
RO80266B (ro) 1983-04-30
US4339450A (en) 1982-07-13
PL228606A1 (es) 1981-08-21
LU83021A1 (fr) 1981-03-27
RO80266A (ro) 1983-04-29
AR225937A1 (es) 1982-05-14
FR2471980A1 (fr) 1981-06-26
CS228143B2 (en) 1984-05-14
PT72247B (fr) 1981-11-05
CH646165A5 (fr) 1984-11-15
DK536180A (da) 1981-06-22
ES497563A0 (es) 1981-11-16

Similar Documents

Publication Publication Date Title
EP0031353A4 (fr) Utilisation de carbone perfluore pour le traitement des brulures.
YU29099A (sh) Derivati 2-(purin-9-il)-tetrahidrofuran-3,4-diola
NO831084L (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive kvartaere dibenzotiepin-n-alkyl-norskopinetere
ES427573A1 (es) Procedimiento para la obtencion de un derivado de etanola- mina.
NO161674C (no) Analogifremgangsm te for fremstilling av terapeutisk aktive 6-substituert-s-triazolo(3,4-a)-ftalazinderivater.
ES482097A1 (es) Procedimiento para preparar derivados acilicos de carnitina.
EP0179808A4 (en) MEDICINAL COMPOSITION SUITABLE FOR TREATING OR PROPHYLAXIS OF HEART DISORDERS.
ES474493A1 (es) Un procedimiento para la preparacion de amidas de mercaptoa-cidos sustituidos
DE3062981D1 (en) Alkyl-urea derivatives for the treatment of lipometabolic diseases; process for their preparation, their use in medicaments for the treatment of lipometabolic disorders, medicaments containing them, process for the preparation of the medicaments, and some alkyl-urea derivatives
HK87285A (en) Mercapto-imidazole derivatives,their preparation,mercapto-imidazole derivatives for the treatment of inflammatory diseases and their pharmaceutical compositions
HU178841B (en) Cattle-leader for the prophylactic or therapeutic treatment of cattle
DE3166084D1 (en) Tricyclic cytosine derivatives for use in pharmaceutical preparations and process for their preparation
ES467931A1 (es) Procedimiento para la obtencion de piridinil-aminoalquilete-res
HK1010340A1 (en) The manufacture of compositions for the treatment of cell proliferation disorders
ES483661A1 (es) Procedimiento para la obtencion de derivados de 1,4-dihidro-piridina sila-sustituidos
AU550675B2 (en) Pharmaceutical compositions for the treatment of skin
ES8200886A1 (es) Procedimiento para la preparacion de derivados del amino-1 propanol-2
DE3371515D1 (en) Cycloalkyl derivatives of benzisoselenazolones, process for their preparation and pharmaceutical compositions containing them
GB2022998B (en) Phermaceutical composition for the treatment of neoplasticand other diseases
ZA783131B (en) New medicine useful for the treatment of bacterial affections
ES462387A1 (es) Procedimiento para la obtencion de derivados de 1,4-dihidro-piridin-azucar.
MY103593A (en) Bicyclic compounds, their use as pharmaceuticals, their preparation, and intermediates useful in their preparation
CA1008370A (en) Product for the treatment of keratinous tissues
IL59768A0 (en) New prostaglandin derivatives in the 6-keto-pge series
ZA814902B (en) Novel thiazol-2-yl-oxamic acid derivatives,their preparation and therapeutic agents containing these compounds